BC
NTLA icon

Brookfield Corp’s Intellia Therapeutics NTLA Stock Holding History

Brookfield Corp’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,831
Closed -$478K – 693
2023
Q1 		$478K Buy
+12,831
New +$478K ﹤0.01% 560